NASDAQ:CGC

Canopy Growth Stock Forecast, Price & News

$25.87
+0.21 (+0.82 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$25.57
$26.23
50-Day Range
$22.12
$31.83
52-Week Range
$13.83
$56.50
Volume2.12 million shs
Average Volume5.48 million shs
Market Capitalization$9.91 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.11
30 days | 90 days | 365 days | Advanced Chart
Receive CGC News and Ratings via Email

Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter.


Canopy Growth logo

About Canopy Growth

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.20 out of 5 stars

Medical Sector

960th out of 2,099 stocks

Medicinals & Botanicals Industry

5th out of 32 stocks

Analyst Opinion: 4.1Community Rank: 1.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Canopy Growth (NASDAQ:CGC) Frequently Asked Questions

Is Canopy Growth a buy right now?

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 2 sell ratings, 10 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Canopy Growth stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGC, but not buy additional shares or sell existing shares.
View analyst ratings for Canopy Growth
or view top-rated stocks.

What stocks does MarketBeat like better than Canopy Growth?

Wall Street analysts have given Canopy Growth a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Canopy Growth wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Canopy Growth's next earnings date?

Canopy Growth is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for Canopy Growth
.

How were Canopy Growth's earnings last quarter?

Canopy Growth Co. (NASDAQ:CGC) issued its quarterly earnings data on Monday, May, 31st. The company reported ($1.85) earnings per share for the quarter, missing analysts' consensus estimates of ($0.18) by $1.67. The business earned $167.40 million during the quarter, compared to analysts' expectations of $149.97 million. Canopy Growth had a negative trailing twelve-month return on equity of 18.67% and a negative net margin of 311.30%. The firm's revenue for the quarter was up 45.4% compared to the same quarter last year. During the same period in the prior year, the company posted ($3.72) EPS.
View Canopy Growth's earnings history
.

How has Canopy Growth's stock price been impacted by COVID-19?

Canopy Growth's stock was trading at $13.35 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CGC stock has increased by 93.8% and is now trading at $25.87.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for CGC?

16 Wall Street analysts have issued 1-year price objectives for Canopy Growth's stock. Their forecasts range from $21.10 to $55.00. On average, they expect Canopy Growth's share price to reach $32.90 in the next twelve months. This suggests a possible upside of 27.2% from the stock's current price.
View analysts' price targets for Canopy Growth
or view top-rated stocks among Wall Street analysts.

Who are Canopy Growth's key executives?

Canopy Growth's management team includes the following people:
  • Mr. David Eric Klein, CEO & Director (Age 57, Pay $2.23M)
  • Mr. Rade Nikola Kovacevic, Pres & Chief Product Officer (Age 35, Pay $642.6k)
  • Mr. Michael Alan Lee, Exec. VP & CFO (Age 47, Pay $824.95k)
  • Mr. Thomas Carlton Stewart, VP & Chief Accounting Officer (Age 39, Pay $344.36k)
  • Mr. Phillip Stephen Shaer, Chief Legal Officer (Age 47, Pay $267.83k)
  • Mr. Timothy Rob Saunders F.C.A., FCPA, Strategic Advisor (Age 60, Pay $328.43k)
  • Mr. Andrew MacCorquodale, COO & VP of Operations Transformation
  • Mr. Thomas Shipley IV, Sr. VP of Quality Assurance & Chief Science Officer (Age 32)
  • Ms. Holly Lukavsky, Chief HR Officer
  • Jason Green, Head of Agriculture - Hemp Division

Who are some of Canopy Growth's key competitors?

What is Canopy Growth's stock symbol?

Canopy Growth trades on the NASDAQ under the ticker symbol "CGC."

Who are Canopy Growth's major shareholders?

Canopy Growth's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Morgan Stanley (0.52%), Bank of Nova Scotia (0.47%), D. E. Shaw & Co. Inc. (0.35%), CIBC World Markets Inc. (0.35%), The Manufacturers Life Insurance Company (0.28%) and AdvisorShares Investments LLC (0.25%). Company insiders that own Canopy Growth stock include Phillip Stephen Shaer, Rade Nikola Kovacevic and Tomas Iv Shipley.
View institutional ownership trends for Canopy Growth
.

Which institutional investors are selling Canopy Growth stock?

CGC stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Toronto Dominion Bank, CIBC Asset Management Inc, State of Wisconsin Investment Board, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Voloridge Investment Management LLC, Dimensional Fund Advisors LP, and D. E. Shaw & Co. Inc.. Company insiders that have sold Canopy Growth company stock in the last year include Phillip Stephen Shaer, Rade Nikola Kovacevic, and Tomas Iv Shipley.
View insider buying and selling activity for Canopy Growth
or view top insider-selling stocks.

Which institutional investors are buying Canopy Growth stock?

CGC stock was acquired by a variety of institutional investors in the last quarter, including CIBC World Markets Inc., AdvisorShares Investments LLC, Morgan Stanley, Penserra Capital Management LLC, Mirae Asset Global Investments Co. Ltd., JPMorgan Chase & Co., Roosevelt Investment Group LLC, and Alberta Investment Management Corp.
View insider buying and selling activity for Canopy Growth
or or view top insider-buying stocks.

How do I buy shares of Canopy Growth?

Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Canopy Growth's stock price today?

One share of CGC stock can currently be purchased for approximately $25.87.

How much money does Canopy Growth make?

Canopy Growth has a market capitalization of $9.91 billion and generates $414.03 million in revenue each year. The company earns $-1,322,470,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis.

How many employees does Canopy Growth have?

Canopy Growth employs 4,434 workers across the globe.

What is Canopy Growth's official website?

The official website for Canopy Growth is www.canopygrowth.com.

Where are Canopy Growth's headquarters?

Canopy Growth is headquartered at 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The company can be reached via phone at 855 558 9333 or via email at [email protected]


This page was last updated on 6/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.